Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.

Li Y, Feng D, Wang Z, Zhao Y, Sun R, Tian D, Liu D, Zhang F, Ning S, Yao J, Tian X. · 2019

Read Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. by Li Y, Feng D, Wang Z, Zhao Y, Sun R, Tian D, Liu D, Zhang F, Ning S, Yao J, Tian X. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6889315.txt.

Introduction

Li and co-authors report a study in Cell Death and Differentiation on gut injury after blood flow returns. Cutting blood supply to the intestine, then restoring it, paradoxically wounds the tissue. Ferroptosis, an iron-driven cell death stoked by damaged fats, was a suspect. Most studies watch the reperfusion phase. This team watched the starved phase before it.

Signs of ferroptosis rose right after ischemia, peaking near 30 minutes of reperfusion. The guard protein GPx4 fell while damage markers climbed. An enzyme called ACSL4, switched on by ischemia, prepares the fats that ferroptosis burns. Blocking that axis eased the injury in their tests. The authors argue the death decision starts before flow returns.

Catalog record

CREATORLi Y, Feng D, Wang Z, Zhao Y, Sun R, Tian D, Liu D, Zhang F, Ning S, Yao J, Tian X.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6889315

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion By Yang Li, Dongcheng Feng, Zhanyu Wang, Yan Zhao, Ruimin Sun, Donghai Tian, Deshun Liu, Feng Zhang, Shili Ning, Jihong Yao, Xiaofeng Tian Published in: Cell Death and Differentiation DOI: 10.1038/s41418-019-0299-4 ABSTRACT Ferroptosis is a recently identified form of regulated cell death defined by the iron-dependent accumulation of lipid reactive oxygen species. Ferroptosis has been studied in various diseases such as cancer, Parkinson’s disease, and stroke. However, the exact function and mechanism of ferroptosis in ischemia/reperfusion (I/R) injury, especially in the intestine, remains unknown. Considering the unique conditions required for ferroptosis, we hypothesize that ischemia promotes ferroptosis immediately after intestinal reperfusion. In contrast to conventional strategies employed in I/R studies, we focused on the ischemic phase. Here we verified ferroptosis by assessing proferroptotic changes after ischemia along with protein and lipid peroxidation levels during reperfusion. The inhibition of ferroptosis by liproxstatin-1 ameliorated I/R-induced intestinal injury. Acyl-CoA synthetase long-chain family member 4 (ACSL4), which is a key enzyme that regulates lipid composition, has been shown to contribute to the execution of ferroptosis, but its role in I/R needs clarification. In the present study, we used rosiglitazone (ROSI) and siRNA to inhibit ischemia/hypoxia-induced ACSL4 in vivo and in vitro. The results demonstrated that ACSL4 inhibition before reperfusion protected against ferroptosis and cell death. Further investigation revealed that special protein 1 (Sp1) was a crucial transcription factor that increased ACSL4 transcription by binding to the ACSL4 promoter region. Collectively, this study demonstrates that ferroptosis is closely associated with intestinal I/R injury, and that ACSL4 has a critical role in this lethal process. Sp1 is an important factor in promoting ACSL4 expression. These results suggest a unique and effective mechanistic approach for intestinal I/R injury prevention and treatment. INTRODUCTION Intestinal ischemia/reperfusion (I/R) injury, which is associated with a high mortality rate, occurs in numerous clinical pathologies such as small intestinal volvulus, acute mesenteric ischemia, shock, and trauma. Intestinal I/R injury can be induced by some surgical approaches such as small bowel transplantation [1–3]. Massive epithelial cell death is a major cause of intestinal mucosal barrier dysfunction, which leads to systemic inflammation and dysfunction of remote organs [4]. Recently, I/R injury events have been increasingly shown to involve nonapoptotic pathways such as necroptosis [5, 6], pyroptosis [7, 8], and ferroptosis [9, 10], which has attracted substantial attention and intense interest. Ferroptosis, a recently recognized form of regulated cell death (RCD), is identified as iron-dependent and caspase-independent nonapoptotic cell death [11]. Ferroptosis differs from other classical nonapoptotic cell death programs by its characteristics of mitochondrial shrinkage and increased mitochondrial membrane density (morphological), iron and lipid reactive oxygen species (L-ROS) accumulation (biochemical), and involvement of a unique set of genes (genetic) [12, 13]. The biochemical mechanism underlying ferroptosis is the iron-catalyzed formation of lipid radicals combined with the depletion of glutathione (GSH) or the inactivation of the lipid repair enzyme GSH peroxidase 4 (GPx4) [14, 15]. Lipid peroxidation is essential for ferroptosis and involves the preferential oxidation of arachidonic acid (AA) and its esterifiable production phosphatidylethanolamine (PE) [16–18]. Both are types of abundant polyunsaturated fatty acids (PUFAs) in the intestinal epithelium [19, 20]. PUFAs can be oxidized into metabolites (e.g., hydroxyeicosatetraenoic acids (HETEs)) during the ferroptosis process [9, 21–23]. Treatment with L-ROS inhibitors such as liproxstatin-1 can suppress this lethal process [9, 24, 25]. Ferroptosis has been implicated in several pathophysiological contexts such as degenerative diseases, tumor suppression, antiviral immunity, and stroke [12, 13]. Recent studies indicate that liproxstatin-1 alleviates I/R-induced liver injury in mice [9], and that deferoxamine, compound 968, and ferrostatin-1, all of which inhibit glutaminolysis and ferroptosis, limit myocardial I/R injury ex vivo [10]. However, the relevance of ferroptosis in intestinal I/R is still unexplored and remains enigmatic. Conventional I/R studies have focused on the reperfusion phase and are of limited translational value. However, although it is part of this dynamic process, the ischemic phase is often overlooked [26]. Chouchani et al. [27] have reported that succinate accumulation during ischemia contributes to reperfusion injury in multiple organs; in contrast with the traditional outlook, this study focused on the ischemic phase. This study not only provided new insight into I/R but also indicated a potential avenue for effective clinical interventions. These findings prompted us to explore the possibility of a certain core regulator induced by ischemia that could lead to ferroptosis immediately after reperfusion in the intestine. Acyl-CoA synthetase long-chain family member 4 (ACSL4) has been studied as a crucial factor in metabolism-associated diseases [28]. ACSL4 was recently found to facilitate the esterification of arachidonoyl (AA) and adrenoyl into PE, a process closely related to ferroptosis [21, 22]. Suppression of this process by genetic and pharmacological ACSL4 inhibition triggers an antiferroptotic rescue pathway [21]. Thus, ACSL4 has been identified as not only a sensitive regulator of ferroptosis but also an important contributor to ferroptosis [29]. To date, ACSL4 has rarely been reported in I/R-related diseases. Hence, the functional role and significance of ACSL4 and its correlation with ferroptosis need to be deeply understood in the context of intestinal I/R injury. Special protein 1 (Sp1) is a classical and well-studied transcription factor that can activate target genes by binding to GC-box elements in promoter regions [30–32]. Previous studies reported that hypoxia induced Sp1 expression in the nucleus and led to cell injury [33, 34]. As predicted, the ACSL4 gene contains many GC boxes and could be a potential target of Sp1. However, the correlation between Sp1 and ACSL4 in I/R injury associated with ferroptosis remains unknown. In this study, we hypothesize that ferroptosis participates in intestinal I/R injury, and that the activation of ACSL4 during ischemia contributes to ferroptosis after reperfusion. Our findings demonstrate that the inhibition of ferroptosis is a critical mechanism protecting against intestinal I/R injury. Inhibition of ACSL4 rescues the tissue injury caused by I/R-mediated ferroptosis in the intestine. We aim to provide a new viewpoint and target in the treatment of intestinal I/R injury. MATERIALS AND METHODS Murine model of intestinal ischemia and I/R Male C57BL/6 mice (8 weeks old, specific pathogen-free) were purchased from the Animal Center of Dalian Medical University (Dalian, China). The mice were fed standard food and water, and were acclimated to the environment before use. All mice were anesthetized by an intraperitoneal (i.p.) injection of pentobarbital (50 mg/kg body weight). To establish the ischemia model, a midline laparotomy was performed and the superior mesenteric artery was occluded by a microvascular clamp for 30, 45, or 60 min without reperfusion. To establish the I/R model, the clamp was removed after 45 min of occlusion and the blood supply was recovered for various durations as required for the present study. All procedures were conducted according to the Institutional Animal Care Guidelines and were approved by the Institutional Ethics Committee of Dalian Medical University. Cell culture, hypoxia, and hypoxia/reoxygenation procedures Caco-2 cells were purchased from the American Type Culture Collection (HTB-37, USA) and cultured in a humidified incubator maintained at 37 °C and 5% CO2 in Dulbecco’s modified Eagle’s medium (11965, Gibco, MD, USA) containing 10% fetal bovine serum (0500, ScienCell, CA, USA), 1% non-essential amino acids (M7145, Sigma, MO, USA) and 1% glutamine (G3126, Sigma). The cell line

Read the complete text